A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)
Clinical trial NCT00746694 · COMPLETED
Trial details
- NCT number
- NCT00746694
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2007-10-01
- Primary completion
- 2009-06-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.